Global CannaVigilance Cannabis Newsletter 2022 / 8

April 13, 2022 | Category : Global CannaVigilance | Posted By : Team Cannavigia

Hello friends of CannaVigilance,  

Tomorrow, Thursday 14th April, the Cannabis Business Club will take place in Zurich. We are looking forward to talking to inspiring people from politics, business and science about the latest developments in the cannabis industry. In this Global CannaVigiliance newsletter, you’ll find an interview with CB Club founder Ben Arn, as well as insight into two other events. And finally, we’re thrilled to be part of Prohibition Partners’ latest European Cannabis Report.   

Small gathering with a big impact 

In anticipation of tomorrow’s  CB Club, we spoke with the creative and inspirational mind behind the event. Ben Arn started the CB Club during the Covid restrictions and liked the small size of the event so much that he decided to keep it as it was – a small, intimate and exclusive gathering to network and get inspiration. 

Read the interview in full   

cannabis cb club cannavigilance

Cannabis extraction is the latest trend in Thailand 

With the cannabis industry in Thailand having slowly opened up over the past few years, the big players who already set up their own cultivation to meet the lack of supply in the early days, are now focusing their efforts on extraction and end-user products with CBD. This is one of the key lessons we learned at the Cannabis Business Asia Conference in late March. We’ve put together the key takeaways of the conference and summarized where we think the Asian cannabis market, and Thailand’s in particular, is headed. Read more here

cannabis Thai cannavigilance

Do you want to find out more about the Cannavigia software in Thailand?

Contact Micheline who is in charge of Business Development in Asia. 

CBD Show in London  

End-user products with CBD will be one of the main topics of discussion at the CBD Show in London on April 22 and 23. More than 5’000 B2B, B2C and B2G business owners, retailers, industry experts, investors and pharmacists are expected to exhibit and attend the show. Our Head of Consulting Elias Galantay will be on site to talk about the latest trends and updates in the market. If you are in London at the end of April, please feel free to make an appointment with him.   

Schedule a meeting with Elias 

Cannavigia & the European Cannabis Report 

At the beginning of this month, Prohibition Partners published the 7th edition of the European Cannabis Report. We highly recommend the report not only to learn the latest information and analysis on medical cannabis, CBD and adult-use cannabis, but also to read the interview with Cannavigia’s CEO Luc Richner and COO Philipp Hagenbach. We are very proud and grateful that Prohibition Partners gave us the opportunity to be featured in their latest report. You can read the interview on page 55 here

A vigilant eye on cannabis news:  

  • Sticking to Thailand and developments there: Thailand’s reputation as one of the strictest countries in the world for drug offences is well documented. Even cannabis, considered a “less dangerous drug” by the UN, carries the potential for a 15 year prison term. But a recent announcement that it is to be delisted as a narcotic could trigger a transformation in how the drug is used inside Thailand.  “A lot of people come here to get their faces fixed with plastic surgery. A lot of people come to do dental work and oral surgery, and for wellness retreats. Within that context, marijuana will integrate beautifully”, says Carl K Linn, author of a newsletter about cannabis in Thailand.  
  • The impact of growing medical cannabis is having an impact on African economies. Zimbabwe’s tobacco industry is looking to cannabis as a major revenue source with anti-tobacco sentiment expected to dampen demand for one of the country’s biggest exports. And airtight 10-gram packets of Ugandan cannabis have been on sale in German pharmacies since the beginning of January. Having helped growers  in Zimbabwe for over a year, Cannavigia is on the pulse of this fast-developing industry.  
  • Large-scale trials of medical cannabis in the UK will begin “as soon as possible”, the department of Greece expects huge investments in the production of medical cannabis, Minister for Development and Investment Adonis Georgiadis said. He also claimed that medical cannabis would be produced and sold in Greece in the beginning of 2022. Georgiadis said a big investment by Τikun Εurope near the city of Corinth is already complete and two more investments from companies in the U.K. and Canada are on the cards for the production of medical cannabis in Macedonia and Patra. 
  • The UK has become the first country in the world to regulate the public sale of orally administered, legal cannabinoids following the publication last week of a list of permitted products. The move will serve to “de-risk” cannabidiol for investors and spur innovation in the space, according to Steve Moore, founder of UK-based trade group the Association for the Cannabinoid Industry 
  • More than half of Europeans favour legalizing cannabis, a new study shows – a bullish sign for entrepreneurs and investors seeking to capitalize on the industry’s growth. 

Newsletter Sign-up